Cookie Policy

Par Pharmaceutical, Inc.

Filing Date
August 17, 2022
Case Number
Southern District of New York

Assets: $1B-$10B

Liabilities: $1B-$10B


On August 17, 2022 Par Pharmaceutical, Inc. filed for chapter 11 protection in the Southern District of New York (Case No. 22-22546). The Debtor reports Assets of $1B-$10B and Liabilities of $1B-$10B. The Petition states funds will be available to Unsecured Creditors.

Per Claims Agent:

Endo initiated the financial restructuring process after reaching an agreement with a group of its senior debtholders on a transaction that would substantially reduce outstanding debt, address remaining opioid and other litigation-related claims, and best position Endo for the future. This will allow the Company to advance its ongoing business transformation from a strengthened financial position to create compelling value for its stakeholders over the long term.

Endo's day-to-day operations, ordinary course investments, collaborative engagement with customers and partners, and focus on its mission will continue as usual – without interruption.

Endo's India-based entities are not part of the Chapter 11 proceedings. The Company expects to file recognition proceedings in Canada, the United Kingdom, and Australia.

Debtor Represented by:

Paul D. Leake

Skadden, Arps, Slate, Meagher & Flom LLP

Company Information:

6 Ram Ridge Road

Chestnut Ridge, NY 10977

Map to Debtor

Share this Filing

Press Release:
Note: we do not represent the Debtor in this case and this information is obtained from automated sources and may not be 100% accurate.
Petition image
Computer image
New! Dockets